Results 201 to 210 of about 77,670 (298)

T‐Cell‐Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS‐CoV‐2 Infection

open access: yesAdvanced Science, Volume 12, Issue 15, April 17, 2025.
This study describes the development of spike‐targeting T‐cell‐dependent bispecific full‐length human immunoglobulin Gs with enhanced efficacy in the treatment of COVID‐19. The significance of T‐cell‐based immunity during infection is highlighted. These results have significant implications for better clinical effectiveness of therapies for COVID‐19 ...
Wenyan Fu   +8 more
wiley   +1 more source

Potent Inhibition of Viral Entry and Replication of SARS-CoV by siRNAs Targeting the Genes Encoding the Cellular ACE2 Receptor or the Viral Nucleocapsid Protein

open access: green, 2007
Xiaomin Yan   +9 more
openalex   +1 more source

Comparison of the pathogenicity and neutrophil and monocyte response between SARS‐CoV‐2 prototype and Omicron BA.1 in a lethal mouse model

open access: yesAnimal Models and Experimental Medicine, Volume 8, Issue 4, Page 707-717, April 2025.
We conducted clinical characterization studies and performed virological evaluations on mice infected with SARS‐CoV‐2 prototype and Omicron BA.1 using RT‐PCR, HE and immunohistochemistry staining. We also studied the alterations of neutrophils and monocytes caused by the two strains using complete blood count, immunohistochemistry, and flow cytometry ...
Na Rong   +8 more
wiley   +1 more source

The Regulation Role of the Gut-Islets Axis in Diabetes

open access: yesDiabetes, Metabolic Syndrome and Obesity
Songtao Yang,1 Jie Cao,1 Chuan Sun,2 Li Yuan1 1Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 2Department of Emergency Medical, Wuhan ASIA ...
Yang S, Cao J, Sun C, Yuan L
doaj  

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10. [PDF]

open access: yesInt J Mol Sci
Gutzler C   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy